title: The value of pharmaceuticals--some direction for employers.
abstract: The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.
authors.affiliation: MEDSTAT Group, Inc., Washington, D.C., USA.
authors.forename: Ron Z
authors.initials: RZ
authors.lastname: Goetzel
authors.forename: Ronald J
authors.initials: RJ
authors.lastname: Ozminkowski
authors.forename: David C
authors.initials: DC
authors.lastname: Schutt
mesh_terms: D003362:Cost-Benefit Analysis; D003657:Decision Making; D004194:Disease / Q000145:classification / Q000191:economics; D016527:Drug Costs / Q000639:trends; D004358:Drug Therapy; D017049:Employer Health Costs / Q000639:trends; D006264:Health Benefit Plans, Employee / Q000191:economics* / Q000458:organization & administration; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D014481:United States